Measurement of malondialdehyde (MDA) level in rat plasma after simvastatin treatment using two different analytical methods

Periodicum Biologorum

Volumn 110, Issue 1, 2008, Pages 63-67

  Lovrić, Jasna ^a   Mesić, Milan ^b   Macan, Marija ^a   Koprivanac, Marijan ^c   Kelava, Marta ^c   Bradamante, Vlasta ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

HPLC MS; Lipid peroxidation; Malondialdehyde; Oxidative stress; Simvastatin; Spectrophotometry; Statins

Indexed keywords

MALONALDEHYDE; SIMVASTATIN; STATEKS 20; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERLIPIDEMIA; INTERMETHOD COMPARISON; KRUSKAL WALLIS TEST; MALE; MASS SPECTROMETRY; NONHUMAN; RAT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STEEL TEST; ULTRAVIOLET SPECTROPHOTOMETRY;

RATTUS; RATTUS NORVEGICUS;

EID: 42549144439     PISSN: 00315362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. BERRIDGE M V TAN A S, McCOY K D, WANG R 1996 The biochemical and cellular basis of cell proliferation assay that use tetrazolium salts. Biochemica 4: 15-20
2. HALLIWELL B, GUTTERIDGE J M C 2000 Free Radicals in Biology and Medicine. Third edition. Oxford Science Publications, New York, Oxford University Press.
3. OHARA Y, PETERSON T E, SAYEGH H S, SUBRAMANIAN R R, WILCOX J N, HARRISON D G 1995 Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. Circulation 92: 898-903
4. 2 isoprostanes in hypercholesterolemia. Circulation 98: 2822-28
5. STEINBERG D, PARTHASARATHY S, CAREW T E, KHOO J C, WITZTUM J L 1989 Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. New Engl J Med 120: 915-24
6. KUGIYAMA K, KERNS S A, MORRISETT J D, ROBERTS R, HENRY P D 1990 Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 144: 160-62
7. FROSTEGARD J, HAEGERSTRAND A, GIDLUND M, NILSSON J 1991 Biologically modified LDL increases the adhesive properties of endothelial cells. Atherosclerosis 90: 119-26
8. FROSTEGARD J, NILSSON J, HAEGERSTRAND A, HAMSTEN A, WIGZELL H, GIDLUND M 1990 Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci USA 87: 904-08
9. KOBA S, PAKALA R, WATANABE T, KATAGIRI T, BENEDICT C R 2000 Synergistic interaction between thromboxane A2 and mildly oxidized low density lipoproteins on vascular smooth muscle cell proliferation. Prostaglandins Leukot Essent Fatty Acids 63: 329-35
10. REGNSTROM J, NILSSON J, TORNVALL P, LANDOU C, HAMSTEN A 1992 Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 339: 1183-86
11. RAITAKARI O T, TOIKKA J O, LAINE H, AHOTUPA M, IIDA H, VIIKARI J S 2001 Reduced myocardial flow reserve relates to increased carotid intima-media thickness in healthy young men. Atherosclerosis 156: 469-75
12. TOIKKA J O, LAINE H, AHOTUPA M, HAAPANEN A, JORMA S A, VIIKARI J J, HARTIALA, J, RAITAKARI O T 2000 Increased arterial intima-media thickness and in vivo LDL oxidation in young men with borderline hypertension. Hypertension 36: 929-33
13. JANERO D R 1990 Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9: 515-40
14. GRAY J I 1978 Measurement of lipid oxidation: A review. J Am Oil Chem Soc 55: 539-46
15. FKANKEL E N, NEFF W E 1983 Formation of malonaldehyde from lipid oxidation product. Biochim Biophys Acta 754: 264-70
16. MELTON S L 1983 Methodology for following lipid oxidation in muscle foods. Food Technol 37: 105-9
17. ANGULO A J, ROMERA J M, RAMIREZ M, GILA 1998 Effects of storage conditions on lipid oxidation in infant formulas based on several protein sources. J Am Oil Chem Soc 75: 1603-07
18. VASANKARI T, AHOTUPA M, TOIKKA J, MIKKOLA J, IRJALA K, PASANEN P 2001 LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy. Atherosclerosis 155: 403-12
19. SASAKI S, KUWAHARA N, KUNITOMO K, HARADA S, YAMADA T, AZUMA A, TAKEDA K, NAGAWA M 2002 Effects of atorvastatin on oxidized low-density lipoprotein, low density lipoprotein subtraction distribution, and remnant lipoprotein in patients with mixed hyperlipoproteinemia. Am J Cardiol 89: 386-89
20. ROSENSON R S, WOLFF D, TANGNEY C C 2004 Statins reduce oxidized low-density lipoprotein levels, but do not alter soluble intercellular cell-adhesion molecule-1 and vascular cell-adhesion molecule-1 levels in subjects with hypercholesterolaemia. Clin Sci (Lond) 106: 215-17
21. BOTSOGLOU N A, FLETOURIS D J, PAPAGEORGIOU G E, VASSILOPOULOS V N, MANTIS A J, TRAKATELLIS A G 1994 Rapid, sensitive and specific thiobarbituric acid method for measuring lipid peroxidation in animal tissue, food and feedstuff samples. Agric Food Chem 42: 1931-37
22. BELTOWSKI J, WÜJCICKA G, MYDLARCZYK A, JAMROZ A 2002 Cerivastatin modulates plasma paraoxonase/arylesterase activity and oxidant-antioxidant balance in the rat. Pol J Pharmacol 54: 143-50
23. BELTOWSKI J, WÜJCICKA G, JAMROZ A 2002 Differential effect of 3-hydroxy-3-methyl-glutarylcoenzyme A reductase inhibitors on plasma paraoxonase 1 activity in the rat. Pol J Pharmacol 54: 661-71
24. NAKASHIMA A, OHTAWA M, IWASAKI K, WADA M, KURODA N, NAKASHIMA K 2001 Inhibitory effects of fluvastatin and its metabolites on the formation of several reactive oxvgen species. Life Science 69: 1381-89
25. ŠKRHA J, ŠTULC T, HILGERTOVA, WEISEROVA H, KVASNIČKA J, ČEšKA R 2004 Effect of simvastatin and fenofibrat on endothelium in Type 2 diabetes. Eur J Pharmacol 493: 183-89